Key result
Older age, male sex, high BMI, and diabetes linked to persistent sleep apnea and abnormal sleep duration.
Why the study?
Prospective changes in obstructive sleep apnea and sleep durations in Hispanic/Latinos, and their links to cardiometabolic risk factors, were unknown.
Do baseline cardiometabolic risk factors predict persistent sleep apnea and abnormal sleep duration in Hispanic/Latino adults?
Cohort (n=1,662)
Do baseline cardiometabolic risk factors predict persistent sleep apnea and abnormal sleep duration in Hispanic/Latino adults?
Effect estimate: RRR 1.15 to 5.53
In a large cohort of Hispanic/Latino adults, older age and poorer baseline cardiometabolic health predicted persistent sleep apnea and abnormal sleep duration over a decade of follow-up.
May aid OSA risk stratification in at-risk Hispanics; leaves open whether cardiometabolic interventions modify sleep aging trajectories.
Introduction Prospective changes in obstructive sleep apnea (OSA) and sleep durations in Hispanic/Latinos are unknown. Understanding the impact of cardiometabolic risk factors on the longitudinal burden of OSA and abnormal sleep duration will be essential for advancing sleep aging research. This study aimed to measure these changes and their correlations in HCHS/SOL. Methods We analyzed data from HCHS/SOL Visit 1 (2008–2011) who returned to complete an ancillary study on sleep and brain health, sleep in neurocognitive aging and Alzheimer’s research (SANAR; 2022–ongoing). At both visits, participants completed home sleep apnea tests and self-reported sleep duration categorized as abnormal (-< 7 hours or ≥9 hours) and recommended (7–< 9 hours). Prospective change categories included abnormal-to-recommended, consistently-recommended, and consistently-abnormal sleep duration. The respiratory event index (REI3%) was categorized into < 15 at both visits, transient-elevated (≥15 at any time), and persistent-elevated (≥15 at both visits). Multinomial logistic regression examined associations with Body Mass Index (BMI), baseline hypertension, prediabetes, and diabetes adjusting for age and sex. Results We examined 1,662 participants (67% female; mean age 67.5 years, SD = 6.4). From V1 to SANAR, the mean sleep duration increased (7.8±1.3 to 8.5±1.5 hrs.), REI3% doubled (7.5±12 to 14±16.6), and BMI was stable (29.9±5.3 to 30.1±6.5). At visit-1, 36% had hypertension, 47% pre-diabetes and 22% diabetes. Male sex, older age, baseline pre-diabetes and diabetes, and higher BMI were associated with higher relative risk ratios (RRR) for REI3% ≥15 at SANAR (range: RRRdiabetes=1.13 to RRRmale=3.73) and for persistent REI3%≥15 across both visits (range: RRR-BMI=1.15 to RRR-male=5.53). Older age, baseline hypertension, prediabetes, and diabetes were associated with increased RRR for long sleep duration at SANAR (range: RRRhypertension=1.09 to RRRage75+=1.92) and for transitioning from recommended to abnormal sleep duration (range: RRRdiabetes=1.09 to RRRage75+=1.50). Males had a lower probability of long sleep duration and of transitioning to abnormal sleep duration. Conclusion Preliminary prospective analyses in a large sample of Hispanic/Latino adults show that older age and poorer cardiometabolic health predict persistent sleep apnea and abnormal sleep duration. These findings support strategies to improve sleep and cardiometabolic health in the aging population. Support (if any) R01AG063868
No takes yet. Share an insight, caveat, or question.
Junco et al. (2026) conducted a cohort in Obstructive sleep apnea and abnormal sleep duration (n=1,662). Cardiometabolic risk factors (BMI, hypertension, prediabetes, diabetes) was evaluated on Prospective changes in obstructive sleep apnea (REI3%) and sleep duration (RRR 1.15 to 5.53). Older age, male sex, higher BMI, and baseline diabetes were associated with increased relative risk for persistent sleep apnea (RRR range 1.15-5.53) and abnormal sleep duration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: